ctDNA monitoring as a biomarker for response and survival in CUP patients receiving ICI therapy
By applying the above combined targeted NGS/sWGS sequencing strategy, we analyzed the dynamic changes in ctDNA levels from plasma samples serially collected in parallel with radiological assessment according to RECIST v1.1 during combined ICI treatment (Fig. 